Back to results
US 2021/0260087 A1Published application
Glycoalkaloid combinations and various uses thereof
OwnerBill Elliot Cham, Tania Robyn Chase +1inventors
InventorsBill Elliot Cham, Tania Robyn Chase, Kai Elliot Cham
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of glycoalkaloids, such as solasonine and solamargine, in treatment of cancer such as skin cancer, and to compositions for use in such treatment. More particularly the present invention relates to providing an improved, substantially stable formulation for the glycoalkaloids which minimises or reduces degradation of these active molecules.
Claims22
A topical composition comprising at least a glycoalkaloid, at least one viscosity modifier and at least one keratolytic agent.
(canceled)
22-31. (canceled)
Dependencies are inferred from the claim text.